About
Media
Members
Board of Directors
Become a Member
The AMP Act
About
Media
Members
Board of Directors
Become a Member
The AMP Act
Media
Filters
Category:
Categories
Member's Corner
Press Releases
Resources
Statements
Uncategorized
Date:
Resources
Axios Lunch with SAMS Director David Sanders
September 19, 2023
Press Releases
SAMS Formally Endorses Two New Pieces of Legislation to Mitigate Future Drugs Shortages, Secure Pharmaceutical Supply Chain
September 12, 2023
Member's Corner
An Urgent Call to Revive the U.S. Pharmaceuticals Supply Chain
September 7, 2023
Press Releases
SAMS Urges Congress and Administration to Address Drug Shortage Crisis in Must Pass Pandemic and All-Hazards Preparedness Act (PAHPA)
July 10, 2023
Statements
SAMS Applauds Senate Majority Whip Durbin for Highlighting Cancer Drug Shortages
June 12, 2023
Press Releases
Securing America’s Medicines and Supply (SAMS) Calls for Construction Authorities to be Included in Pandemic Preparedness Reauthorization Bill
May 24, 2023
Press Releases
SAMS Commends Congress for Finally Recognizing Importance of American-made Supply Chain Issues
May 17, 2023
Press Releases
SAMS Member US Biologic Receives USDA Conditional Licensure for Novel Oral Vaccine
May 11, 2023
Press Releases
SAMS Statement of Support for the Reintroduction of the MADE in America Act
April 28, 2023
Press Releases
SAMS Applauds Launch of Bipartisan Domestic Pharmaceutical Manufacturing Caucus
March 30, 2023
Press Releases
SAMS Advocates to Boost Prescription Drugs in Shortage
February 10, 2023
Press Releases
SAMS Statement on the Establishment of the Select Committee on the Strategic Competition Between the U.S. and the CCP
January 12, 2023
Press Releases
SAMS Statement on Passage of The Consolidated Appropriations Act of 2023
December 23, 2022
Resources
Op-Ed: To protect the medical supply chain, ‘made in America’ will be key
December 14, 2022
Press Releases
SAMS Statement on Shortages of Critical Medicines in the United States
December 7, 2022
Resources
New Study Finds U.S. Manufacturers Operating at Half Capacity
November 23, 2022
Press Releases
SAMS Comments on Shortages of Flu-fighting Pharmaceuticals
November 21, 2022
Press Releases
SAMS Applauds the Appointment of Livia Shmavonian as the Director of the White House ‘Made in America’ Office
November 3, 2022
Press Releases
SAMS Response to the Biden Administration’s $2 Billion Investment in Biomanufacturing
September 15, 2022
Statements
SAMS Response to National Biotechnology and Biomanufacturing Initiative
September 12, 2022
1
2